You will receive alerts when there are new announcements on Paradigm Biopharmaceuticals Ltd
Only registered members can use this feature.
Paradigm Biopharmaceuticals Ltd (ASX:PAR) is listed on the Australian Securities Exchange.
Earlier this month, Paradigm reported a 45% mean reduction in pain score across 34 patients with knee osteoarthritis (OA) using Zilosul.
Copyright © Proactive Investors 2019.
All Rights Reserved - Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.